Loading asset research
CervoMed Inc. Common Stock
CRVONasdaq · USD · StocksQuote as of · Exchange session not verified$2.57
+3.63%
Today
CRVO
Loading 1D prices…
Market cap
$38.9M
Volume
233.8K
52w high
$10.0052w low
$2.13Company profile
CervoMed Inc. Common Stock
CervoMed Inc., a clinical-stage biotechnology company, engages in the development and commercialization of treatments for age-related neurologic disorders. The company is developing neflamapimod, an orally administered small molecule drug that crosses the bloodbrain barrier and inhibits the enzyme p38a. Neflamapimod has the potential to reverse synaptic dysfunction, improve neuron health, and slow or prevent disease progression. Neflamapimod is currently in clinical development for the treatment of dementia with Lewy bodies, non-fluent variant primary progressive aphasia, amyotrophic lateral sclerosis, and amyotrophic lateral sclerosis. CervoMed Inc. was founded in 2010 and is headquartered in Boston, Massachusetts.
Sector
Health Care
Industry
Pharmaceutical Preparations
Exchange
Nasdaq
Display currency
USD
Location
BOSTON, MA, United States
Employees
15
Fiscal year end
1231
CIK
1053691
Session & valuation
Open$2.54
Previous close$2.48
Day high$2.64
Day low$2.50
30-day avg. volume300.5K
Outstanding shares15.1M
Diluted EPS-$2.98
Latest annual period
P/E (trailing)-0.86
P/E (forward)-1.74
Price / book1.51
Beta-4.31
Dividend yield—
Deterministic peer set
Companies with SEC SIC 2834
Exact regulatory industry matches, ranked by nearest market capitalization.
| Company | Market cap | Revenue | Net margin | Diluted EPS | Today | Consensus |
|---|---|---|---|---|---|---|
| IXHLIncannex Healthcare Inc. Common Stock | $39M | $86K | -19547.67% | -$1.51 | +0.31% | Hold |
| NSRXNasus Pharma Ltd. Ordinary Shares | $39.9M | $1.2B | -0.47% | -$0.72 | +1.64% | Buy |
| LITSLite Strategy Inc. Common Stock | $37.8M | $0.00 | — | -$1.68 | +4.72% | Hold |
| FLNAFilana Therapeutics Inc. Common Stock | $37.3M | $0.00 | — | -$1.88 | -4.94% | Buy |
| EDSAEdesa Biotech Inc. Common Shares | $40.8M | $0.00 | — | -$1.27 | -9.23% | Buy |